Civeo Corporation (CVEO) sees 5.8% stake disclosed by American Century group

American Century entities and the Stowers Institute filed an SEC Schedule 13G for Civeo Corporation (CVEO). American Century Investment Management, American Century Companies, and Stowers each reported 640,269 shares, 5.8% of the class, with sole voting and dispositive power. American Century ETF Trust reported 615,126 shares, 5.6%.

Original reporting
Published Aug 14, 2026, 12:28 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 15, 2026, 1:08 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CVEO
Neutral
medium confidence
Mentioned
$CVEO
Relevance
5/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CVEONeutralLow
01

Why it matters

The disclosure establishes that these parties collectively hold about 5.8% (and the ETF trust 5.6%) of Civeo’s common stock with sole voting and dispositive power, but it does not describe activism or corporate actions.

02

Market read

This is a fresh ownership datapoint for CVEO, useful for monitoring shareholder concentration and potential future activism, but it is not a direct operational catalyst.

03

What to watch

Traders should check whether any other filings (e.g., Schedule 13D, additional amendments) follow, which would indicate a change from passive to active intent.

Relevance 5/10Novelty 5/10Timing: today’s read-through of a newly filed Schedule 13G ownership disclosure

Background

The article summarizes an SEC Schedule 13G amendment reporting beneficial ownership by American Century entities and the Stowers Institute for Medical Research.

Company-level read

Ticker impact

$CVEONeutralMedium confidence
Context

American Century entities disclosed passive beneficial ownership of 640,269 shares, or 5.8%, in Civeo common stock via SEC Schedule 13G.

Expected impact

Likely limited, with any move driven by sentiment around ownership concentration rather than fundamentals.

Evidence & confidence

The filing is a Schedule 13G beneficial ownership disclosure (passive, sole voting/dispositive power) and does not indicate an activist campaign, tender offer, or operational change.

Market effects

Minimal direct sector impact; this is company-specific ownership reporting rather than an industry catalyst.

None indicated.

None indicated.

Counterpoint

A 5.8% passive stake may be purely index or allocation-driven and may not change trading behavior meaningfully.

Key entities

  • Civeo Corporation

    Subject of the Schedule 13G beneficial ownership disclosure.

  • American Century Investment Management, Inc.

    Reported beneficial ownership of 640,269 shares (5.8%) with sole voting and dispositive power.

  • American Century Companies, Inc.

    Reported beneficial ownership of 640,269 shares (5.8%) as the parent controlling entity.

  • Stowers Institute for Medical Research

    Stated as controlling American Century Companies, Inc. per the filing.

  • American Century ETF Trust

    Reported beneficial ownership of 615,126 shares (5.6%) with sole voting and dispositive power.

Related articles

$CVEOMed

Civeo Corp (CVEO) Q3 2026 Earnings Call Highlights: Raised Guidance, Canada Momentum

Civeo Corp (CVEO) raised its guidance for Q3 2026, citing strong demand and pricing momentum, particularly in Canada. The company expects tighter market conditions due to major projects like Coastal GasLink. Management noted that Bowen Basin occupancy is softer due to customer cost pressures, while Australian integrated services are growing. U.S. data center opportunities are dynamic but challenging. Civeo aims for A$500 million in annual integrated services revenue by year-end 2027.

$CVEOMedAI 8/10

What Civeo (CVEO) Said on Its Q3 Earnings Call

Civeo (CVEO) raised its 2026 capex outlook to $30M-$35M and expects new mobile-camp rooms to be deployed by mid-Q1 2027. Australian revenue rose 4% to AUD 129.5M, but adjusted EBITDA fell. The company has $126.9M available under its credit facility and has repurchased 26% of its shares since 2025.

$CVEOMedAI 8/10

Civeo (CVEO) Q3 2026 Earnings Call Transcript

Civeo (CVEO) reported Q3 2026 earnings with adjusted EBITDA of $30.1M, up 5% YoY, driven by Canada. Revenue increased 13% YoY to $193.1M. Australia's revenue rose 4% in USD due to currency effects, but local revenue declined 4%. Canada saw a 35% YoY increase in billed rooms. The company repurchased 20% of shares and expects to complete 10% more. CapEx guidance was increased for Canadian asset deployment.